Top Markets
#1 Black Phoenix Black Phoenix +826.11%
#2 pipedog pipedog +30.60%
#3 FGRS (Figure Tokenized Stock) FGRS (Figure Tokenized Stock) +26.23%
#4 SAFEcoin SAFEcoin +25.88%
#5 Beam Beam +22.88%
#6 PondCoin PondCoin +22.65%
#7 Bless Bless +21.86%
#8 Magma Finance Magma Finance +20.15%
#9 Prom Prom +17.56%
#10 YFSX YFSX +15.96%
Coin of the day
Black Phoenix Black Phoenix
設定
言語
日本
通貨
USD
テーマ
Zymeworks Inc. Zymeworks Inc.

Zymeworks Inc.

ZYME
株式のランク #6243
Zymeworks Inc. is a biopharmaceutical firm in the clinical development phase,... Zymeworks Inc. is a biopharmaceutical firm in the clinical development phase, dedicated to identifying, advancing, and bringing to market biological therapies aimed at combating cancer. Its pipeline features two primary experimental treatments: zanidatamab, a cutting-edge bispecific antibody currently undergoing Phase 1 and Phase 2 studies for various malignancies such as those affecting the biliary tract, gastroesophageal region (adenocarcinomas), breast, and colon; and ZW49, an antibody-drug conjugate targeting two sites on the human epidermal growth factor receptor 2 (HER2), which is in Phase 1 trials for advanced or spreading tumors that express HER2. Zymeworks maintains significant alliances with several pharmaceutical leaders, including Merck Sharp & Dohme Research Ltd., Eli Lilly and Company, Bristol-Myers Squibb company, GlaxoSmithKline Intellectual Property Development Ltd., Daiichi Sankyo Co., Ltd., Janssen Biotech, Inc., BeiGene, Ltd., and Exelixis, Inc. Furthermore, it engages in cooperative research and licensing agreements with LEO Pharma A/S, specifically for the exploration, advancement, and market introduction of bispecific antibodies, and with Iconic Therapeutics, Inc. Established in 2003, Zymeworks Inc. operates from its headquarters located in Vancouver, Canada.
株価
$29.10
時価総額
$2.14B
変化（1日）
-0.71%
変化（1年）
94.89%
国
US
取引 Zymeworks Inc. (ZYME)

カテゴリー

Healthcare
Zymeworks Inc.（ZYME）の配当利回りの履歴
Zymeworks Inc.（銘柄コード: ZYME）の配当利回り（TTM）は2026時点で0です。
過去5年間の平均配当利回り: 0.00%
Zymeworks Inc.（ZYME）の2026から2026までの配当利回りの履歴
各年末時点の配当利回り（TTM）
年 配当利回り 変化
提供された日付のデータは十分ではありません。
類似企業または競合他社の配当利回り（TTM）
企業 配当利回り 国
Vertex Pharmaceuticals Incorporated Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated
VRTX.US
0.00%
US
Argenx SE Argenx SE
Argenx SE
ARGX.US
0.00%
NL
CSL Limited CSL Limited
CSL Limited
CSL.AX
3.12%
AU
Moderna, Inc. Moderna, Inc.
Moderna, Inc.
MRNA.US
0.00%
US
Lonza Group AG Lonza Group AG
Lonza Group AG
LONN.SW
0.00%
CH